Atorvastatin reduces total-C (total cholesterol), LDL-C (low-density lipoprotein cholesterol), and apo B (apolipoprotein B). Atorvastatin also reduces VLDL-C (very-low-density lipoprotein cholesterol) and TG (triglycerides) and produces variable increases in HDL-C (high-density lipoprotein cholesterol).
Before instituting therapy with atorvastatin, an attempt should be made to control hypercholesterolemia with appropriate diet, exercise and weight reduction in obese patients, and to treat underlying medical problems. The patient should continue on a standard cholesterol-lowering diet during treatment with atorvastatin.
Doses may be given any time of the day, with or without food.
Total cholesterol: 8.3 mmol/L (Margin: 5.2)
Triglycerides: 1.05 mmol/L (Margin: 1.7)
HDL: 1.74 mmol/L (Levels should be above 1 in men)
LDL: 6.1 mmol/L (Margin: 3.4)
療程︰Atorvastin 20 mg (每日一粒) 先服兩個月
(參考資料︰MIMS, ncbi.nlm.nih.gov)
沒有留言:
發佈留言